<DOC>
	<DOCNO>NCT00730223</DOCNO>
	<brief_summary>To see certain variation CYP2B6 gene contribute difference plasma drug level central nervous system side affect people take nevirapine efavirenz .</brief_summary>
	<brief_title>Genetic Determinants Metabolism Non-nucleoside Reverse Transcriptase Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Healthy African American men woman . 1855 year age . Willing able provide write informed consent . Currently recently ( within previous 30 day ) receive medication know likely metabolize , interact wth CYP450 enzymes . Prior current hepatic psychiatric disease illness judgment investigator would interfere study performance . Active alcohol illicit drug abuse use judgment investigator would interfere study performance . Alanine Aminotransferase ( ALT ) Aspartate Aminotransferase ( AST ) &gt; 1.5 X upper limit normal . Positive pregnancy test woman childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Nevirapine</keyword>
	<keyword>Efavirenz</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy</keyword>
	<keyword>CYP2B6</keyword>
	<keyword>HIV/AIDS</keyword>
</DOC>